STOCK TITAN

Nkarta to Participate in November Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Nkarta (Nasdaq: NKTX) will participate in two investor conferences in November 2025: a Stifel 2025 Healthcare Conference fireside chat on November 12, 2025 at 10:40 a.m. ET and a TD Cowen Immunology & Inflammation Summit fireside chat on November 13, 2025 at 5:00 p.m. ET. A simultaneous webcast will be available on the company’s Investors website at www.nkartatx.com, and a replay will be archived on the site for approximately 90 days.

Nkarta (Nasdaq: NKTX) parteciperà a due conferenze per investitori a novembre 2025: una chiacchierata informale durante la Stifel 2025 Healthcare Conference il 12 novembre 2025 alle 10:40 ET e una chiacchierata informale durante la TD Cowen Immunology & Inflammation Summit il 13 novembre 2025 alle 17:00 ET. Una webcast simultanea sarà disponibile sul sito degli investitori dell’azienda all’indirizzo www.nkartatx.com, e una replica sarà archiviata sul sito per circa 90 giorni.

Nkarta (Nasdaq: NKTX) participará en dos conferencias para inversionistas en noviembre de 2025: una conversación informal durante la Stifel 2025 Healthcare Conference el 12 de noviembre de 2025 a las 10:40 a.m. ET y una TD Cowen Immunology & Inflammation Summit conversación informal el 13 de noviembre de 2025 a las 5:00 p.m. ET. Una transmisión web simultánea estará disponible en el sitio de inversores de la empresa en www.nkartatx.com, y una reproducción quedará archivada en el sitio por aproximadamente 90 días.

Nkarta (Nasdaq: NKTX)는 2025년 11월에 두 차례의 투자자 컨퍼런스에 참여할 예정입니다: Stifel 2025 Healthcare Conference의 파이어사이드 채팅이 2025년 11월 12일 오전 10:40 ET에, TD Cowen Immunology & Inflammation Summit의 파이어사이드 채팅이 2025년 11월 13일 오후 5:00 ET에 각각 열립니다. 동시 생중계는 회사의 투자자 웹사이트 www.nkartatx.com에서 제공되며, 재방송은 약 90일간 사이트에 보관됩니다.

Nkarta (Nasdaq: NKTX) participera à deux conférences destinées aux investisseurs en novembre 2025 : un fireside chat lors de la Stifel 2025 Healthcare Conference le 12 novembre 2025 à 10h40 ET et un fireside chat lors du TD Cowen Immunology & Inflammation Summit le 13 novembre 2025 à 17h00 ET. Une diffusion web simultanée sera disponible sur le site des investisseurs de l’entreprise à l’adresse www.nkartatx.com, et une rediffusion sera archivée sur le site pendant environ 90 jours.

Nkarta (Nasdaq: NKTX) wird im November 2025 an zwei Investorenkonferenzen teilnehmen: ein Fireside-Chat bei der Stifel 2025 Healthcare Conference am 12. November 2025 um 10:40 EST und ein Fireside-Chat bei der TD Cowen Immunology & Inflammation Summit am 13. November 2025 um 17:00 EST. Eine gleichzeitige Webcast wird auf der Investoren-Website des Unternehmens unter www.nkartatx.com verfügbar sein, und eine Wiedergabe wird auf der Seite für ca. 90 Tage archiviert.

Nkarta (Nasdaq: NKTX) ستشارك في مؤتمرين للمستثمرين في نوفمبر 2025: جلسة Fireside أثناء Stifel 2025 Healthcare Conference في 12 نوفمبر 2025 الساعة 10:40 صباحاً بتوقيت شرق الولايات المتحدة وجلسة Fireside أثناء TD Cowen Immunology & Inflammation Summit في 13 نوفمبر 2025 الساعة 5:00 مساءً بتوقيت شرق الولايات المتحدة. ستتوفر بث حي متزامن على موقع الشركة للمستثمرين على www.nkartatx.com، وسيتم حفظ إعادة البث على الموقع لمدة تقارب 90 يوماً.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conferences next month:

Stifel 2025 Healthcare Conference
November 12, 2025
10:40 a.m. ET – fireside chat

TD Cowen’s Immunology & Inflammation Summit
November 13, 2025
5 p.m. ET – fireside chat

A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com

Nkarta Media/Investor Contact:
Nadir Mahmood
Nkarta, Inc.
nmahmood@nkartatx.com


FAQ

When will Nkarta (NKTX) speak at the Stifel 2025 Healthcare Conference?

Nkarta will speak on November 12, 2025 at 10:40 a.m. ET in a fireside chat.

What time is Nkarta (NKTX) scheduled for TD Cowen’s Immunology & Inflammation Summit?

Nkarta’s fireside chat is scheduled for November 13, 2025 at 5:00 p.m. ET.

How can investors watch Nkarta (NKTX) presentations live on November 12 and 13, 2025?

A simultaneous webcast will be available on Nkarta’s Investors website at www.nkartatx.com.

Will Nkarta (NKTX) provide a replay of the November 2025 conference presentations?

Yes. A replay will be archived on the company’s investor website for approximately 90 days.

Are Nkarta’s (NKTX) November 2025 conference sessions live events or prerecorded?

The announcements describe the sessions as fireside chats with a simultaneous live webcast available.
Nkarta, Inc.

NASDAQ:NKTX

NKTX Rankings

NKTX Latest News

NKTX Latest SEC Filings

NKTX Stock Data

148.44M
67.19M
5.02%
86.47%
12.35%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO